Common examples include liraglutide and semaglutide , which have been approved for type 2 diabetes and obesity management
PRESS RELEASE PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in 2026 Companies confirm that markers of weight loss and glycemic control are distinct in preliminary study, with multiple mechanisms identified that provide opportunities to guide indication extension OXFORD, UK and PORTLAND, ME 15 April 2026 Ovation.io, a leading human omics and clinical data company, and PrecisionLife, a precision medicine company transforming how complex chronic diseases are understood and managed, today announced that they have reached agreement to commercialize the outputs of PrecisionLifes analysis of Ovations high quality GLP-1 receptor agonist dataset
Your healthcare provider will assess these possibilities through history-taking, examination, and appropriate investigations
Symposium to Analyze Amylin as Novel Therapy for Diabetes and Weight Loss
The study is a review or a case study